Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

213.56 +2.73 (+1.29%)
Official Closing Price Updated: 4:15 PM EDT, Aug 21, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
News headline image
Healthcare Sector Update: Life in the Slow Lane while we wait for BIOTECH Bounce ↗
Healthcare sector lags despite moderate growth. Note bad news from CVS and Humana. 
Via Talk Markets
News headline image
Key Index And Sectors Are Inside Last Week’s Range ↗
The ultimate technical pattern that represents indecision is when by midweek, the price range remains stuck inside the trading pattern of the week prior. 
Via Talk Markets
News headline image
Biotech Stocks Poised For Another Big Move In Q4 ↗
The healthcare sector can be a safe haven if volatility increases. 
Via Talk Markets
News headline image
Biotech Stocks : Are You A Trader Or A Longer Term Investor? ↗
Biotech bull market is intact as indicated by large cap biopharma and the best performing funds. 
Via Talk Markets
News headline image
Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
The Federal Reserve's recent 50bps rate cut could significantly boost biotech companies by lowering borrowing costs and improving access to capital. 
Via MarketBeat
Topics ETFs Economy
News headline image
Biotech Breakout: Stocks for Your Watchlist
The iShares Biotechnology ETF (IBB) has turned $140 resistance into support, positioning the overall sector for a potential breakout above $150. 
Via MarketBeat
Topics ETFs
News headline image
The S&P 500 Surges As “Shiny Objects” Distract Investors ↗
The big index was up nicely today. Verizon (VZ) and Nvidia led the way as Apple (AAPL) failed to dazzle with its product-line reveal. 
Via Talk Markets
Topics Stocks
News headline image
Economic Modern Family-The Good, Bad and Ugly ↗
When we examine the weekly charts, we see a return to August lows possible. We see a return to May lows as a gift. Let's take a deeper dive... 
Via Talk Markets
News headline image
Market Thoughts This Labor Day Weekend ↗
For this long weekend, I am offering you food for thought. In the overall macro theme, I am sticking to this for time being: Stagflation - The Fed can’t fix it with a huge reduction in rates, that will... 
Via Talk Markets
Topics Economy
News headline image
3 ETFs for Growth Investors to Buy and Hold for Decades ↗
These exchange-traded funds can help you easily tap into some promising growth opportunities. 
Via The Motley Fool
Topics ETFs
News headline image
Did Granny Retail And Buffett Save The Equities Market? ↗
XRT told us a lot after the economic data already out earlier in the week (CPI PPI), and then the retail sales and earnings reports that came out today. 
Via Talk Markets
News headline image
ETFs Where Are They Now? ↗
Did this past week really resolve which way the Modern Family wants to go from here? In some ways yes and other ways no. 
Via Talk Markets
Topics ETFs
News headline image
Divided We Stood, United We Fall ↗
Considering the bifurcation of the sectors and that the Long Bonds TLT were already flashing risk off, this week’s unified selling comes as no surprise. 
Via Talk Markets
News headline image
Monday Quarterbacking The Major Sector ETFs ↗
All but Retail XRT. But XRT only garnered a rally early in the day and settled within last week’s range. 
Via Talk Markets
News headline image
Healthcare Stocks Are Coming On Strong In July Led By Biotech ↗
The biotech rally gained momentum in July with rotation out of technology stocks. 
Via Talk Markets
News headline image
The 3 Best ETFs to Buy for the Small-Cap Revival ↗
With the Street starting to become enthusiastic about small-cap stocks,, here are the three best small-cap ETFs to buy. 
Via InvestorPlace
Topics ETFs
News headline image
The Long Bonds Update ↗
Should TLT clear July highs, we see a potential shift in the landscape with fears of recession starting to emerge. 
Via Talk Markets
Topics Economy
News headline image
Biotech Bull Market Is Intact But SMIDs Are Too Volatile ↗
It was another wild week for the market as it had to contend with a lot of news. 
Via Talk Markets
News headline image
The Market Requires 7 Pairs Of Eyes! ↗
A disjointed technical picture means that investors should respect the weaker seasonality. Investors should respect the strong sectors and not overthink. We have learned that regardless of political... 
Via Talk Markets
News headline image
CPI Data Sparks Rally in Biotech Stocks
Following lower-than-expected inflation data on Thursday, The biotech sector broke out above resistance, closing the week up 6%, far outperforming the market. 
Via MarketBeat
Topics ETFs Economy
News headline image
Smalls And Mids Bios Try To Take The Lead While 2 Stocks Are On Watch For Pullback Entries ↗
What an interesting week it was! It was about time, but the IWM finally broke out. I know it's lagging, so why do I like this breakout better? Because it's different. 
Via Talk Markets
News headline image
Market Tries To Read Between The Lines ↗
We have heard many discussions on whether small caps, like the Russell 2000 index really matter for the market. Do we care about the small caps? Is there a correction coming in large caps? 
Via Talk Markets
News headline image
TSLA Hit Our Target - Here’s What’s Next ↗
We’ll look at another big mover right now: precious metals. They still look good after Fed Chair Jerome Powell tried to talk down rate cuts today. 
Via Talk Markets
Topics Economy
News headline image
Can Momentum Build In Small Caps? ↗
IWM has not cleared the Bollinger Band or zero line in Leadership since 2023. Hence, until we see some real Leadership IWM is rangebound. 
Via Talk Markets
News headline image
Quarterly & Long-Term Portfolios For The Win ↗
What a day for Meta! I was planning to add to my position, but the volume was too low. I would have been shaken out of most of it for the swing before it could become this position trade. 
Via Talk Markets
News headline image
3 Highly Rated Biotech Stocks for Your July Buy List ↗
Discover three top-rated biotech stocks that are pushing forward the pharma and biotech revolution on Wall Street. 
Via InvestorPlace
News headline image
AbbVie Stock: A Perfect Dip for Investors to Buy
ABBV stock is down over 3% to start the second half of the year; the stock may be overvalued in the short term but still offers value for long-term investors 
Via MarketBeat
Topics ETFs
News headline image
Tesla And Tech Are Still Taking The Bulls Higher ↗
While we’ve seen some compelling signs that the market is ready for new leadership, tech is still presenting problems for the bears. 
Via Talk Markets
News headline image
Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
The biotech sector (IBB) is trading just 3% away from its 52-week high and a significant resistance level, suggesting a potential breakout. 
Via MarketBeat
Topics ETFs
News headline image
Top Performing Industry ETFs In June: Software Leads Returns, Chipmakers Attract Most Inflows ↗
June saw gains in the U.S. stock market, with tech and biotech leading the way. Semiconductor ETFs saw strong inflows, while utilities lagged. 
Via Benzinga
Topics ETFs
< Previous 1 2 3 4 5 6 7 8 9
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.